Predictive Oncology Inc (POAI)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Jul 03, 16:00
Predictive Oncology Cash from Financing (Quarterly): -0.1124M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.1124M |
| December 31, 2023 | -0.1113M |
| September 30, 2023 | 0.2602M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0236M |
| September 30, 2022 | -0.004M |
| June 30, 2022 | 6.656M |
| March 31, 2022 | 0.0869M |
| December 31, 2021 | -0.0375M |
| September 30, 2021 | 0.0148M |
| June 30, 2021 | 20.03M |
| March 31, 2021 | 30.34M |
| December 31, 2020 | 0.6492M |
| September 30, 2020 | 2.429M |
| June 30, 2020 | 3.964M |
| March 31, 2020 | 5.911M |
| December 31, 2019 | 2.855M |
| September 30, 2019 | 1.931M |
| June 30, 2019 | 0.8979M |
| March 31, 2019 | 3.636M |
| December 31, 2018 | 2.185M |
| September 30, 2018 | 0.3089M |
| June 30, 2018 | 0.2854M |
| March 31, 2018 | 3.015M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.30M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 3.815M |
| December 31, 2016 | 1.626M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0863M |
| December 31, 2015 | 0.0099M |
| September 30, 2015 | 12.13M |
| June 30, 2015 | 0.25M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 1.434M |
| June 30, 2014 | 0.105M |
| March 31, 2014 | 1.868M |
| December 31, 2013 | 0.4068M |
| September 30, 2013 | 1.448M |
| June 30, 2013 | 1.005M |
| March 31, 2013 | 1.30M |
| December 31, 2012 | 0.3145M |
| September 30, 2012 | 0.2035M |
| June 30, 2012 | 0.4067M |
| March 31, 2012 | 0.1497M |
| December 31, 2011 | 0.641M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1124M
Minimum
Mar 2024
30.34M
Maximum
Mar 2021
3.938M
Average
0.2602M
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
| icad Inc | -- |
| Perspective Therapeutics Inc | 166.33M |
| Semler Scientific Inc | 0.011M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.416M |
| Cash from Investing (Quarterly) | -0.003M |
| Free Cash Flow | -13.44M |
| Free Cash Flow Per Share (Quarterly) | -0.8415 |
| Free Cash Flow to Equity (Quarterly) | -3.307M |
| Free Cash Flow Yield | -329.4% |